About Epistemix
Epistemix is a company based in Pittsburgh (United States) founded in 2018. Epistemix has raised $11.62 million across 3 funding rounds from investors including Ecliptic Capital. The company has 11 employees as of December 31, 2024. Epistemix offers products and services including Consumer Insights Platform, Forecasting Service, and Scenario Planning Tool. Epistemix operates in a competitive market with competitors including Color, Unite Us, Biobot Analytics, Metabiota and Azara Healthcare, among others.
- Headquarter Pittsburgh, United States
- Employees 11 as on 31 Dec, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Epistemix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$11.62 M (USD)
in 3 rounds
-
Latest Funding Round
$5 M (USD), Series A
Apr 04, 2024
- Investors
-
Employee Count
11
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Epistemix
Epistemix offers a comprehensive portfolio of products and services, including Consumer Insights Platform, Forecasting Service, and Scenario Planning Tool.
Overlays data on synthetic populations for market segmentation.
Identifies trends using population models for strategic planning.
Tests scenarios via AI to minimize decision-making risks.
People of Epistemix
Unlock access to complete
Unlock access to complete
Funding Insights of Epistemix
Epistemix has successfully raised a total of $11.62M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $5 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Epistemix
Epistemix has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Ecliptic Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Epistemix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Epistemix
Investment portfolio details for Epistemix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Epistemix
Detailed financials for Epistemix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Epistemix Comparisons
Peer comparison for Epistemix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Epistemix
Epistemix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Color, Unite Us, Biobot Analytics, Metabiota and Azara Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Cloud-based software for patient interoperability and community management is offered.
|
|
| Locked | Locked | Locked |
Tools are provided to map microbes and chemicals of interest.
|
|
| Locked | Locked | Locked |
Epidemic outbreaks are predicted and controlled through risk analytics.
|
|
| Locked | Locked | Locked |
Population health management is enabled via cloud-based tools for hospitals.
|
|
| Locked | Locked | Locked |
At-home diagnostic kits for STDs are provided via telehealth.
|
Detailed competitors of Epistemix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Epistemix
Complete news archive for Epistemix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Epistemix
Epistemix was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Epistemix is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Epistemix is a funded company, having raised a total of $11.62M across 3 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Epistemix is 11.
Epistemix was founded in 2018 in Pittsburgh, United States, and operates in the healthcare software sector. Online tools are provided for population management, including disease management and community health programs. Services encompass status report generation, computational analysis, and health tracking for government medical organizations, health systems, enterprises, and institutions. The platform supports various healthcare entities through its digital features.
Epistemix's top competitors include Biobot Analytics, Unite Us and Metabiota.
Epistemix offers Consumer Insights Platform, Forecasting Service, and Scenario Planning Tool.
Epistemix has 1 investor. Key investors include Ecliptic Capital.